Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 6, 2004, Pages 949-961

  Hayashi, T ^a   Nishioka, J ^a   Kamada, H ^a   Asanuma, K ^a   Kondo, H ^a   Gabazza, E C ^a   Ido, M ^a   Suzuki, Koji ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Activated protein C; Inflammation; Protein C inhibitor; Tissue expression; Transgenic mice

Indexed keywords

ACTIVATED PROTEIN C; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CLOTTING; BRAIN TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTOXEMIA; EPITHELIUM CELL; FEMALE; GENITAL SYSTEM; HEART; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; KIDNEY EPITHELIUM; LIVER CELL; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TISSUE INJURY; TRANSGENIC MOUSE;

ANIMALS; BLOOD COAGULATION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; PROTEIN C; PROTEIN C INHIBITOR; TISSUE DISTRIBUTION;

EID: 13244249730     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00733.x     Document Type: Article

References (52)

1. Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980; 66: 1186-9.
2. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-8.
3. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 1984; 95: 187-95.
4. Meijers JCM, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988; 27: 4231-7.
5. Rezaie AR, Cooper ST, Church FC, Esmon CT. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995; 270: 25336-9.
6. Yuasa H, Tanaka H, Hayashi T, Wakita T, Nakamura H, Nishioka J, Kawarada Y, Suzuki K. Bovine protein C inhibitor has a unique reactive site and can transiently inhibit plasmin. Thromb Haemost 2000; 83: 262-7.
7. Espana F, Estelles A, Fernandez PJ, Gilabert J, Sanchez-Cuenca J, Griffin JH. Evidence for the regulation of urokinase and tissue plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost 1993; 70: 989-94.
8. Stief TW, Radtke KP, Heimburger N. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hoppe Seyler 1987; 368: 1427-33.
9. Espana F, Gilabert J, Estelles A, Romeu A, Aznar J, Cabo A. Functional active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991; 64: 309-20.
10. Hermans JM, Jones R, Stone SR. Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry 1994; 33 5440-4.
11. Francis RB, Thomas W. Behavior of protein C inhibitor in intravascular coagulation and liver disease. Thromb Haemost 1984; 52: 71-4.
12. Morito F, Saito H, Suzuki K, Hashimoto S. Synthesis and secretion of human protein C inhibitor by hepatoma-derived cell line, HepG2. Biochim Biophys Acta 1985; 884: 209-15.
13. Radtke KP, Fernandez JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH. Protein C inhibitor is expressed in tubular cells of human kidneys. J Clin Invest 1994; 94: 2117-24.
14. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-101.
15. Suzuki K. Protein C inhibitor (PAI-3): structure and multi-function. Fibrinol Proteol 2000; 14: 146-54.
16. Wakita T, Hayashi T, Yuasa H, Nishioka J, Kawamura J, Suzuki K. Molecular cloning, tissue distribution and androgen regulation of rat protein C inhibitor. FEBS Lett 1998; 429: 263-8.
17. Zechmeister-Machhart M, Uhrin P, Hufnagl P, Geiger M, Binder BR. Molecular cloning and tissue distribution of mouse protein C inhibitor (PCI). Immunopharmacol 1996; 32: 96-8.
18. Uhrin P, Dewerchin M, Hilpert M, Chrenek P, Schofer C, Zechmeister-Machhart M, Kronke G, Vales A, Carmeliet P, Binder BR, Geiger M. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest 2000; 106 1531-9.
19. Elisen MG, van Kooij RJ, Nolte MA, Marquart JA, Lock TM, Bouma BN, Meijers JCM. Protein C inhibitor may modulate human sperm-oocyte interactions. Biol Reprod 1998; 58: 670-7.
20. Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, Yamamoto S, Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the serine protease inhibitor superfamily. J Biol Chem 1987; 262: 611-6.
21. Meijers JCM, Chung DC. Organization of the gene coding for human protein C inhibitor (plasminogen activator inhibitor-3). J Biol Chem 1991; 266: 15028-34.
22. Hayashi T, Suzuki K. Gene organization of human protein C inhibitor, a member of SERPIN family proteins encoded in five exons. Int J Hematol 1993; 58: 213-24.
23. Hayashi T, Usui M, Nishioka J, Zhang ZX, Suzuki K. Regulation of the human protein C inhibitor gene expression in HepG2 cells. Role of Sp1 and AP2. Biochem J 1998; 372: 573-82.
24. Zechmeister-Machhart M, Hufnagl P, Uhrin P, Korsschineck I, Binder BR, Geiger M. Molecular cloning and sequence analysis of the mouse protein C inhibitor gene. Gene 1997; 186: 61-6.
25. Crossley M, Ludwig M, Stowell KM, De Vos P, Olek K, Brownlee GG. Recovery from hemophilia B Leyden and androgen-responsive element in the factor IX promoter. Science 1992; 257: 377-9.
26. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997; 407: 313-9.
27. Hayashi T, Nakamura H, Okada A, Takebayashi S, Wakita T, Yuasa H, Okumura K, Suzuki K. Organization and chromosomal localization of the human endothelial protein C receptor gene. Gene 1999; 238 367-73.
28. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1982; 162: 156-9.
30. Minamikawa K, Wada H, Wakita Y, Ohiwa M, Tanigawa M, Deguchi K, Hiraoka N, Fujioka H, Nishioka J, Hayashi T, Suzuki K. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Thromb Haemost 1994; 71: 192-4.
31. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
32. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 1994; 83: 683-90.
33. 26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Thromb Haemost 1996; 75: 275-82.
34. Wagenaar GTM, Hanneke van Vuuren AJ, Girma M, Tiekstra MJ, Kwast L, Koster JG, Rijneveld AW, Elisen MGLM, van der Poll T, Meijers JCM. Characterization of transgenic, mice that secrete functional human protein C inhibitor into the circulation. Thromb Haemost 2000; 83: 93-101.
35. Radtke KP, Fernandez JA, Villoutreix BO, Greengard JS, Griffin JH. Characterization of a cDNA for rhesus monkey protein C inhibitor - evidence for N-terminal involvement in heparin stimulation. Thromb Haemost 1995; 74: 1079-87.
36. Suzuki K, Stenflo J, Dahlback B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-20.
37. Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980; 19: 401-10.
38. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
39. Aoki Y, Ota M, Katsuura Y, Komoriya K, Nakagaki T. Effect of activated protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats. Arzneimittelforschung 2000; 50: 809-15.
40. Griffin JH, Zlokovic B, Fernandez JA. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Sem Hematol 2002; 39: 197-205.
41. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781-7.
42. Schmidt-Supprian M, Murphy C, While B, Lawler M, Kapurniotu A, Voelter W, Smith O, Bernhagen J. Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. Eur Cytokine Netw 2000; 11: 407-13.
43. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. New Engl J Med 2001; 344 699-709.
44. Fujita M, Izutani W, Komurasaki Y. Effect of protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation. Thromb Haemost 2000; 84: 54-8.
45. Meijers JCM, Arnoud Marquart J, Bertina RM, Rosendaal FR. Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis. Br J Haematol 2002; 118: 604-9.
46. Hoogendoorn H, Nesheim ME, Giles AR. A qualitative and quantitative analysis of the activation and inactivation of protein C. Blood 1990; 75: 2164-71.
47. Eapana F, Gruber A, Heeb MJ, Hanson SR, Harker LA, Griffin JH. In vivo and in vitro complexes of activated protein C with two inhibitors in baboon. Blood 1991; 77: 1754-60.
48. Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 1989; 73: 455-61.
49. Watanabe R, Wada H, Mori Y, Nakasaki T, Sawa H, Gabazza EC, Hayashi T, Nishioka J, Suzuki K, Shiku H, Nobori T. Plasma level of activated protein C-protein C inhibitor complex in patients with hypercoagulable state. Am J Hematol 2000; 65: 35-40.
50. Levi M, Dorffler-Melly J, Reitsma PH, Buller HR, Florquin S, Van Der Poll T, Carmeliet P. Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein C-deficient mice. Blood 2003; 101: 4823-7.
51. Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 2004; 108: 516-23.
52. Shimizu S, Gabazza EC, Taguchi O, Yasui H, Taguchi Y, Hayashi T, Ido M, Shimizu T, Nakagaki T, Kobayashi H, Fukudome K, Tsuneyoshi N, D'Alessandro-Gabazza CN, Izumizaki M, Iwase M, Homma I, Adachi Y, Suzuki K. Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med 2003; 167: 1416-26.